WorkBoat Header Background Image

WorkBoat+ Membership – Free to Join

Thank you for another great WorkBoat Show! We hope to see everyone back in New Orleans December 2–4, 2026. Save the date!

Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Allurion Technologies, Inc. Common Stock (NY:ALUR)

1.326 -0.064 (-4.58%)
Streaming Delayed Price Updated: 12:22 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Allurion Technologies, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
From Allurion Technologies, Inc.
Via Business Wire
News headline image
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
News headline image
Preview: Allurion Technologies's Earnings ↗
 
Via Benzinga
News headline image
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
A Look at Allurion Technologies's Upcoming Earnings Report ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
From Allurion Technologies, Inc.
Via Business Wire
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Allurion Revenue Drops 71 Percent in Q2 ↗
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Earnings Scheduled For August 13, 2025 ↗
 
Via Benzinga
News headline image
Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program
From Allurion Technologies, Inc.
Via Business Wire
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
What's going on in today's after hours session ↗
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
News headline image
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS
From Allurion Technologies, Inc.
Via Business Wire
News headline image
Allurion to Present at Jefferies Global Healthcare Conference
From Allurion Technologies, Inc.
Via Business Wire
News headline image
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Privacy Policy DSAR Requests Terms of Use Locations Events, Products & Services
© 2025 Diversified Communications. All rights reserved.